[Recommendations of the study group "Hormone substitution in postmenopause after breast cancer" of the German Society for Breast Diseases].
Maass
H
H
Brändle
L W
LW
von Fournier
D
D
Lauritzen
C
C
Schulz
K D
KD
D001943:Breast Neoplasms / Q000503:physiopathology* / Q000628:therapy; D002979:Climacteric / Q000187:drug effects*; D015914:Estrogen Replacement Therapy / Q000379:methods*; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000503:physiopathology* / Q000628:therapy; D011372:Progestins / Q000008:administration & dosage; D011379:Prognosis; D013629:Tamoxifen / Q000008:administration & dosage
D011372:Progestins; D013629:Tamoxifen
Vorschläge der Arbeitsgruppe "Hormonsubstitution in der Postmenopause nach Mammakarzinom" der Deutschen Gesellschaft für Senologie.